PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31678537-6	2020	Cumulative incidence of VOD/SOS at day 50 was 3.1% after RIC regimen with Flu/Bu2+-ATG (busulfan dose 6.4 mg/kg), compared to 0.15% after Flu/Bu1+-ATG (busulfan dose 3.2 mg/kg) (p=0.0002); the incidence rate was 2.1% after RIC HCT with sirolimus containing GVHD prophylaxis, compared to 0.8% for RIC without sirolimus (p=0.06).	Busulfan	88-96	xylosyltransferase 2	Homo sapiens	28-31	
24174393-6	2014	RESULT: In patients receiving Bu four times per day Bu levels >1,500 micromol/L minute correlate to an increased risk of developing a SOS.	Busulfan	30-32	xylosyltransferase 2	Homo sapiens	137-140	
24174393-6	2014	RESULT: In patients receiving Bu four times per day Bu levels >1,500 micromol/L minute correlate to an increased risk of developing a SOS.	Busulfan	52-54	xylosyltransferase 2	Homo sapiens	137-140